Stahl, S.M.; De Martin, S.; Mattarei, A.; Bettini, E.; Pani, L.; Guidetti, C.; Folli, F.; de Somer, M.; Traversa, S.; Inturrisi, C.E.;
et al. Esmethadone (REL-1017) and Other Uncompetitive NMDAR Channel Blockers May Improve Mood Disorders via Modulation of Synaptic Kinase-Mediated Signaling. Int. J. Mol. Sci. 2022, 23, 12196.
https://doi.org/10.3390/ijms232012196
AMA Style
Stahl SM, De Martin S, Mattarei A, Bettini E, Pani L, Guidetti C, Folli F, de Somer M, Traversa S, Inturrisi CE,
et al. Esmethadone (REL-1017) and Other Uncompetitive NMDAR Channel Blockers May Improve Mood Disorders via Modulation of Synaptic Kinase-Mediated Signaling. International Journal of Molecular Sciences. 2022; 23(20):12196.
https://doi.org/10.3390/ijms232012196
Chicago/Turabian Style
Stahl, Stephen M., Sara De Martin, Andrea Mattarei, Ezio Bettini, Luca Pani, Clotilde Guidetti, Franco Folli, Marc de Somer, Sergio Traversa, Charles E. Inturrisi,
and et al. 2022. "Esmethadone (REL-1017) and Other Uncompetitive NMDAR Channel Blockers May Improve Mood Disorders via Modulation of Synaptic Kinase-Mediated Signaling" International Journal of Molecular Sciences 23, no. 20: 12196.
https://doi.org/10.3390/ijms232012196
APA Style
Stahl, S. M., De Martin, S., Mattarei, A., Bettini, E., Pani, L., Guidetti, C., Folli, F., de Somer, M., Traversa, S., Inturrisi, C. E., Pappagallo, M., Gentilucci, M., Alimonti, A., Fava, M., & Manfredi, P. L.
(2022). Esmethadone (REL-1017) and Other Uncompetitive NMDAR Channel Blockers May Improve Mood Disorders via Modulation of Synaptic Kinase-Mediated Signaling. International Journal of Molecular Sciences, 23(20), 12196.
https://doi.org/10.3390/ijms232012196
